Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|September 23, 2009
Withaferin A targets heat shock protein 90 in pancreatic cancer cellsYanke Yu, Adel Hamza, Tao Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 11, 2025
Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed BioequivalenceDiane Wang, Cathy Cen Guo, Xizhe Gao, et al.
Environmental Science & Technology|October 10, 2022
Rationally Engineering a CuO/Pd@SiO2 Core-Shell Catalyst with Isolated Bifunctional Pd and Cu Active Sites for n-Butylamine Controllable DecompositionMudi Ma, Shuai Xu, Qiyuan Liu, et al.
Environmental Science & Technology|June 20, 2024
Constructing Pd@Layered-CoO/MFI Bifunctional Catalyst for Efficient Ethyl Acetate Oxidation: Boosted C═O Activation and *O Species TransformationChunli Ai, Jialei Wan, Zeyu Jiang, et al.
British Journal of Clinical Pharmacology|March 2, 2022
Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairmentCen Guo, Yanke Yu, Jayeta Chakrabarti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2010
Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cellsYanyan Li, Tao Zhang, Hasan Korkaya, et al.
Cancer Research|May 20, 2016
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic SeverityKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Transplantation and Cellular Therapy|June 1, 2026
A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationShukaib Arslan, Corey Cutler, Amin Alousi, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2021
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese womenBinghe Xu, Huiping Li, Qingyuan Zhang, et al.
The Journal of Nutritional Biochemistry|March 27, 2012
Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50(Cdc37) complex and direct interactions with amino acids residues of Hsp90Yanyan Li, G Elif Karagöz, Young Ho Seo, et al.
Pageof 6